ADVFN - Advanced Financial Network.
HOME» NYSE » B » BEC Stock Price » BEC Stock News

Beckman Coulter Share News

 Beckman Coulter, Inc. Stock Price
BEC Stock Price
 Beckman Coulter, Inc. Stock Chart
BEC Stock Chart
 Beckman Coulter, Inc. Stock News
BEC Stock News
 Beckman Coulter, Inc. Company Information
BEC Company Information
 Beckman Coulter, Inc. Stock Trades
BEC Stock Trades

PerkinElmer, After Beckman-Bid Loss, Is Mulling Deals -Bloomberg

DOW JONES NEWSWIRES Medical-diagnostics supplier PerkinElmer Inc. (PKI) is considering whether to buy another large company or possibly put itself up for sale, after an unsuccessful attempt to acquire Beckman Coulter Inc. (BEC), Bloomberg News reported Thursday, citing people with knowledge of the matter. According to the sources and regulatory filings, PerkinElmer, after months of pursuing Beckman, made the highest bid in the late stages of an auction earlier this month for the Orange County, Calif., medical-equipment company. Danaher Corp. (DHR) ultimately won the auction with a bid of $83.50 a share, or $5.87 billion, just 25 cents a share more than PerkinElmer's offer for Beckman, the sources told Bloomberg. Beckman's board, advised by Goldman Sachs Group Inc. (GS), determined that Danaher represented the best deal for shareholders, according to a Beckman regulatory filing cited by Bloomberg. PerkinElmer had arranged about $7 billion in financing for a purchase, sources said, while Danaher is using cash to fund about 25% of its acquisition, with the remainder in debt and equity. Full story at -Dow Jones Newswires; 212-416-2900

Stock News for Beckman Coulter (BEC)
No Recent News Available

Beckman Coulter and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations